Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 277

    1.

    Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.

    Illingworth DR.

    Ann Intern Med. 1984 Nov;101(5):598-604.PMID: 6567462 [PubMed - indexed for MEDLINE]Related articles

    2.

    Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

    Bilheimer DW, Grundy SM, Brown MS, Goldstein JL.

    Proc Natl Acad Sci U S A. 1983 Jul;80(13):4124-8.PMID: 6575399 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.

    Illingworth DR, Sexton GJ.

    J Clin Invest. 1984 Dec;74(6):1972-8.PMID: 6569064 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Treatment of primary moderate hypercholesterolemia with lovastatin (mevinolin) and colestipol.

    Vega GL, Grundy SM.

    JAMA. 1987 Jan 2;257(1):33-8.PMID: 3537351 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease.

    Kuo PT, Wilson AC, Kostis JB, Moreyra AE.

    Am J Cardiol. 1986 Jun 27;57(16):43H-48H.PMID: 3524177 [PubMed - indexed for MEDLINE]Related articles

    7.

    Combination drug therapy for familial combined hyperlipidemia.

    East C, Bilheimer DW, Grundy SM.

    Ann Intern Med. 1988 Jul 1;109(1):25-32.PMID: 3288029 [PubMed - indexed for MEDLINE]Related articles

    8.

    Complementarity of colestipol, niacin, and lovastatin in treatment of severe familial hypercholesterolemia.

    Malloy MJ, Kane JP, Kunitake ST, Tun P.

    Ann Intern Med. 1987 Nov;107(5):616-23.PMID: 3662275 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.

    Witztum JL, Simmons D, Steinberg D, Beltz WF, Weinreb R, Young SG, Lester P, Kelly N, Juliano J.

    Circulation. 1989 Jan;79(1):16-28.PMID: 2642754 [PubMed - indexed for MEDLINE]Related articles

    10.

    The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia.

    Hoeg JM, Maher MB, Bailey KR, Brewer HB Jr.

    Atherosclerosis. 1986 Jun;60(3):209-14.PMID: 3524586 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia.

    Hoeg JM, Maher MB, Zech LA, Bailey KR, Gregg RE, Lackner KJ, Fojo SS, Anchors MA, Bojanovski M, Sprecher DL, et al.

    Am J Cardiol. 1986 Apr 15;57(11):933-9.PMID: 3515897 [PubMed - indexed for MEDLINE]Related articles

    12.

    Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.

    Illingworth DR, Bacon S.

    Arteriosclerosis. 1989 Jan-Feb;9(1 Suppl):I121-34. Review.PMID: 2492189 [PubMed - indexed for MEDLINE]Related articles

    13.

    Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia.

    Illingworth DR, Phillipson BE, Rapp JH, Connor WE.

    Lancet. 1981 Feb 7;1(8215):296-8.PMID: 6109940 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effects of combined therapy with lovastatin and colestipol in heterozygous familial hypercholesterolemia. Effects on kinetics of apolipoprotein B.

    Vega GL, East C, Grundy SM.

    Arteriosclerosis. 1989 Jan-Feb;9(1 Suppl):I135-44.PMID: 2912427 [PubMed - indexed for MEDLINE]Related articles

    15.

    Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.

    Illingworth DR, Bacon S.

    Circulation. 1989 Mar;79(3):590-6.PMID: 2645064 [PubMed - indexed for MEDLINE]Related articles

    16.

    Lecithin: cholesterol acyltransferase activity in familial hypercholesterolemia treated with simvastatin and simvastatin plus low-dose colestipol.

    Desager JP, Horsmans Y, Harvengt C.

    J Clin Pharmacol. 1991 Jun;31(6):537-42.PMID: 1880219 [PubMed - indexed for MEDLINE]Related articles

    17.

    Normalization of low-density-lipoprotein levels in heterozygous familial hypercholesterolemia with a combined drug regimen.

    Kane JP, Malloy MJ, Tun P, Phillips NR, Freedman DD, Williams ML, Rowe JS, Havel RJ.

    N Engl J Med. 1981 Jan 29;304(5):251-8.PMID: 7003391 [PubMed - indexed for MEDLINE]Related articles

    18.

    Long-term maintenance of therapeutic response to lovastatin in patients with familial and non-familial hypercholesterolemia: a 3-year follow-up.

    Ojala JP, Helve E, Karjalainen K, Tarkkanen A, Tikkanen MJ.

    Atherosclerosis. 1990 May;82(1-2):85-95.PMID: 2360923 [PubMed - indexed for MEDLINE]Related articles

    19.

    Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

    Bilheimer DW, Grundy SM, Brown MS, Goldstein JL.

    Trans Assoc Am Physicians. 1983;96:1-9. Review.PMID: 6388097 [PubMed - indexed for MEDLINE]Related articles

    20.

    How effective is drug therapy in heterozygous familial hypercholesterolemia?

    Illingworth DR.

    Am J Cardiol. 1993 Sep 30;72(10):54D-58D. Review.PMID: 8213497 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data